Jeremy Walsh is an American technology leader specializing in artificial intelligence (AI) and information technology (IT) for healthcare and government sectors. He served as the inaugural Chief AI Officer and Head of IT at the U.S. Food and Drug Administration (FDA), a position to which he was appointed in May 2025. In that newly created role, Walsh oversaw the integration of AI tools to enhance regulatory efficiency, leading initiatives such as the application of generative AI for drug labeling and collaboration with the Department of Veterans Affairs on AI-driven healthcare technologies.

Prior to joining the FDA, Walsh spent 14 years at Booz Allen Hamilton as Chief Technologist, where he designed and delivered AI, cloud computing, and data analytics solutions for federal health agencies including the FDA, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and Department of Veterans Affairs, and held direct contracts supporting FDA operations. Earlier in his career, he served as Chief Technologist at MITRE, a nonprofit providing technical advisory services to the U.S. government, focusing on distributed systems and innovative IT architectures.

Walsh holds a bachelor's degree in computer science from the University of Maryland and brings more than two decades of experience in scaling AI applications to address public sector challenges.